AABB Store

CABP CE Bundle: 36.5 Credits (various programs)

Product Code: CABPCE-2025-36.5

For Recertifying CABPs Only – Exclusive AABB CABP CE Bundle

This specially priced bundle is designed to support current Certified Advanced Biotherapies Professionals (CABPs) in fulfilling their continuing education (CE) requirement. It includes 32 programs that collectively offer 36.5 CABP CE-eligible credits.

All programs in this bundle are available online through AABB’s Education Platform as independent, self-paced learning programs. Upon purchase, you’ll receive immediate access via AABB’s Education Platform.

Important: Each program within the bundle has a specific expiration date. CE credit must be claimed before the expiration date of each individual program.

Programs included:

2024 Annual Meeting On-Demand Sessions

  • AM24-ST-01-O: The Use of HLA-Typed Cellular Transfusions and/or Infusions for In Vivo Adsorption of Donor-Specific HLA Antibodies (DSAs) as a Desensitization Strategy for Hematopoietic Stem Cell Transplant Patients
  • AM24-ST-09-O: Sterility Testing for Cellular Therapies: Updates and Challenges. What Should We Be Doing? 
  • AM24-ST-15-O: Sickle Cell Disease Psychosocial Support and Advocacy
  • AM24-ST-20-O: Enhancing Laboratory Competency with AI: Meeting AABB Standards for Cell Processing Facilities and Blood Banks
  • AM24-ST-21-O: Critical Role of an Assay Lifecycle in Analytical Development for Cell and Gene Therapy Products
  • AM24-SN-01-O: The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells
  • AM24-SN-06-O: Operationalizing Delivery of Gene Therapy for Sickle Cell Disease
  • AM24-SN-09-O: Lesson's Learned Onboarding Cell and Gene Therapy Vendors and Clients in the 21st Century
  • AM24-SN-17-O: Sickle Cell Disease: Inching Towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics
  • AM24-SN-19-O: Viral Vector Systems and Cellular Therapy
  • AM24-MN-01-O: Source Plasma for Further Manufacture and Transfusion Medicine – Finding Common Ground
  • AM24-MN-09-O: Management of Hematotoxicity from Immune Effector Cell Therapy and Sickle Cell Disease Gene Therapy
  • AM24-MN-18-O: Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System
  • AM24-MN-26-O: Overview of Cell-Based Biologics Manufacturing as a Contracted Service
  • AM24-MN-31-O: Cell Therapy: Creative Inventory Management & Discard
  • AM24-MN-32-O: Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think
  • AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation
  • AM24-TU-01-O: Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies
  • AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples
  • AM24-TU-06-O: Oral Abstracts - Biotherapy Spotlight
  • AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection? Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate
  • AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment

On-Demand eCasts

  • 25EL-505 On-Demand eCast: HLA 101: Connecting the Dots for Transfusion and Transplant
  • 25EL-517 On-Demand eCast: What To Do When Your Freezers Are Full: Strategies for Optimizing Cellular Therapy Product Cryopreservation and Storage
  • 25EL-527 On-Demand eCast: Preparative Apheresis and Transfusion Support for Sickle Cell Disease Gene Therapy
  • 25EL-541 On-Demand eCast: Adipose MSC and Their Use in Regenerative Medicine/Biotherapies and Which Regulations Need To Be Followed
  • 25EL-565 On-Demand eCast: Regulatory Considerations for Collecting Cellular Starting Material for Allogeneic Cell and Gene Therapy Manufacture (available August 21, 2025)
  • 25EL-581 On-Demand eCast: Guidance for Coding and Reimbursement for Cell Therapies (available October 2, 2025)
  • 25EL-593 On-Demand eCast: Addressing Common Nonconformances from AABB and How to Prevent Them (available November 20, 2025) 
  • 24EL-402 On-Demand eCast: Improving HPC Inventory Management - Considerations Regarding Consent and Discard of Cryopreserved HPC Products
  • 24EL-416 On-Demand eCast: Navigating Clinical Trials - Quality Agreement Essentials for Cell Processing Facilities
  • 23EL-890 On-Demand eCast: Stem Cell Tourism

List Price: $1266.00
Sale: $309.00

Member Price: $1107.00
Sale: $279.00

Want to save more?

Log in to see if you qualify for a lower rate. Members save $30.00 or more.

Join Us